ST
PACB icon

Spot Trading’s Pacific Biosciences PACB Stock Holding History

Spot Trading’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-40,817
Closed -$297K – 3063
2016
Q3 		$366K Buy
40,817
+7,950
+24% +$66.5K 0.01% 1703
2016
Q2 		$231K Buy
+32,867
New +$300K ﹤0.01% 2118

Other funds holding PACB

Credit Agricole
Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Spot Trading's PACB Position: Q4 2016 in Review

Spot Trading sold out of Pacific Biosciences (PACB) in Q4 2016, closing a stake of 40,817 shares — an estimated $297K sold.

Spot Trading first reported a position in PACB in Q2 2016 and held it in 2 quarters. The position peaked at $366K in Q3 2016. 115 funds tracked by Wall St. Rank hold PACB as of Q4 2016.

  • Spot Trading reported no remaining Pacific Biosciences position as of Q4 2016 after selling out during the quarter.
  • Spot Trading sold 40,817 Pacific Biosciences shares in Q4 2016, an estimated $297K.
  • Spot Trading first reported a position in Pacific Biosciences in Q2 2016 and held it in 2 quarters.
  • Spot Trading's Pacific Biosciences position peaked at $366K in Q3 2016.
  • 115 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2016.

Based on Spot Trading's 13F filing for Q4 2016, filed 7 Feb 2017.